Collaborative Matrix Factorization with Soft Regularization for Drug-Target Interaction Prediction

被引:0
作者
Li-Gang Gao
Meng-Yun Yang
Jian-Xin Wang
机构
[1] Central South University,School of Computer Science and Engineering
[2] Central South University,Hunan Provincial Key Laboratory of Bioinformatics
[3] Shaoyang University,School of Science
来源
Journal of Computer Science and Technology | 2021年 / 36卷
关键词
drug-target interaction; collaborative matrix factorization; soft regularization; noisy data;
D O I
暂无
中图分类号
学科分类号
摘要
Identifying the potential drug-target interactions (DTI) is critical in drug discovery. The drug-target interaction prediction methods based on collaborative filtering have demonstrated attractive prediction performance. However, many corresponding models cannot accurately express the relationship between similarity features and DTI features. In order to rationally represent the correlation, we propose a novel matrix factorization method, so-called collaborative matrix factorization with soft regularization (SRCMF). SRCMF improves the prediction performance by combining the drug and the target similarity information with matrix factorization. In contrast to general collaborative matrix factorization, the fundamental idea of SRCMF is to make the similarity features and the potential features of DTI approximate, not identical. Specifically, SRCMF obtains low-rank feature representations of drug similarity and target similarity, and then uses a soft regularization term to constrain the approximation between drug (target) similarity features and drug (target) potential features of DTI. To comprehensively evaluate the prediction performance of SRCMF, we conduct cross-validation experiments under three different settings. In terms of the area under the precision-recall curve (AUPR), SRCMF achieves better prediction results than six state-of-the-art methods. Besides, under different noise levels of similarity data, the prediction performance of SRCMF is much better than that of collaborative matrix factorization. In conclusion, SRCMF is robust leading to performance improvement in drug-target interaction prediction.
引用
收藏
页码:310 / 322
页数:12
相关论文
共 70 条
  • [1] Morgan S(2011)The cost of drug development: A systematic review Health Policy 100 4-17
  • [2] Grootendorst P(2019)Drug repurposing: Progress, challenges and recommendations Nature Reviews Drug Discovery 18 41-58
  • [3] Lexchin J(2000)Drug discovery: A historical perspective Science 287 1960-1964
  • [4] Cunningham C(2005)Keynote review: in vitro safety pharmacology profiling: An essential tool for successful drug development Drug Discovery Today 10 1421-1433
  • [5] Greyson D(2007)Relating protein pharmacology by ligand chemistry Nature Biotechnology 25 197-206
  • [6] Pushpakom SP(2006)TarFisDock: A web server for identifying drug targets with docking approach Nucleic Acids Research 34 W219-W224
  • [7] Iorio F(2019)Computational prediction of drug-target interactions using chemogenomic approaches: An empirical survey Briefings in Bioinformatics 20 1337-1357
  • [8] Eyers PA(2009)Supervised prediction of drug-target interactions using bipartite local models Bioinformatics 25 2397-2403
  • [9] Drews J(2013)Drug-target interaction prediction by learning from local information and neighbors Bioinformatics 29 238-245
  • [10] Whitebread S(2018)RFDT: A rotation forest-based predictor for predicting drug-target interactions using drug structure and protein sequence information Current Protein and Peptide Science 19 445-454